US$ 23.78
amgen glp 1 drug π The next trillion-dollar war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's GLP-1 drugs. New pills, monthly injections and next-generation obesity Amgen's AMG-133 shows potential in
Description
They require monitoring from a licensed medical professional

The initial dosing regimen of liraglutide is 0.6 mg subcutaneously daily, with the dose increased to up to 3 mg for Saxenda and 1.8 mg for Victoza , usually after one week at the previous dose

Both medications were well tolerated with no reported side effects

After screening by title and abstract, 16 articles were available to be assessed in full-text screening

Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes 2026
